DRTS
RadTechAlpha Tau Medical Ltd.
Chart
At a glance
No thesis note yet.
Price & volume signals
Technical signals from price history, for your own read of market timing. These never affect the Estimated Price — they sit apart from the valuation by design.
· Only 47 bars — the 50/200-day averages need more history.
Fundamentals
Position
No open position. Record a trade on the Portfolio tab and it flows into this card.
Status
No multi-year arc can be constructed: there are zero fiscal years of revenue on file and only a single fiscal year of financials exists, so revenue CAGR and growth volatility are not computable. The only available snapshot is for 2025-12-31, showing revenue of 0, EBITDA of -42,288,000, and net income of -42,627,000; no filing events are available to tie these to a trajectory.
As of 2025-12-31, the company has no revenue, EBITDA of -42,288,000, net income of -42,627,000, cash of 12,202,000, zero total debt, and equity of 77,099,000. No active flags are present, so there are no computed warning or positive indicators to incorporate.
Estimated cash runway of ~3-4 months ($12.2M cash vs. -$42.3M TTM EBITDA) is far below the 24-month threshold for a pre-revenue name ahead of a value-inflection readout.
critical · rule-runway
No qualitative outlook data available for this market yet — this market's filings are not parsed for management outlook, strategic priorities, or capex plans. The forward view rests on the valuation assumptions and any pending recalibration only.
Synthesized by deepseek-v4-flash over already-extracted filing facts, trajectory stats, and computed flags. Interpretation only — it moves no valuation number.
Filings & extraction
No filings ingested yet.
News & signals
No signals for this name.
Illustrative data where noted. Not investment advice.